Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
S. Stroobants (Leuven, Belgium). Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer. Annual Congress 2008 - New imaging modalities in the staging of lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD Source: ERJ Open Res, 7 (3) 00699-2020; 10.1183/23120541.00699-2020 Year: 2021 The place of non-invasive techniques (CT - PET - CT) Source: Annual Congress 2007 - Mediastinal staging for NSCLC Year: 2007 Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002 Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Positron emission tomography in the diagnostic work-up of screening-detected lung nodules Source: Eur Respir J 2015; 45: 501-510 Year: 2015